Reviva Pharmaceuticals Holdings Inc. Warrants (25/12/2025) RVPHW 深 沪
已收盘 12-12 16:00:00 美东时间
0.003
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.003
- 总市值 2.77万
- 52周最高 0.3678
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.003
- 委 比 0.00%
- 总股本 923.17万
- 历史最高 3.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.003
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Reviva Pharmaceuticals Holdings Inc <RVPH.OQ> expected to post a loss of $1.17 a share - Earnings Preview
Reviva Pharmaceuticals Holdings Inc expected to post a loss of $1.17 a share - Earnings Preview Reviva Pharmaceuticals Holdings Inc RVPH.OQ RVPH.O is expected to show no change in quarterly revenue when it reports results on March 30 (estimated) for the period ending December 31 2025 LSEG's mean
03-27 20:27
What's Behind The Drop In Reviva Pharmaceuticals Stock?
Reviva Pharmaceuticals shares are tumbling Thursday after pricing a $10 million public offering of over 6 million shares at $1.50 per share.
03-20 00:49
BUZZ-U.S. STOCKS ON THE MOVE-Rivian, Biohaven, CervoMed
BUZZ-U.S. STOCKS ON THE MOVE-Rivian, Biohaven, CervoMed Workspace search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 March 19 (Reuters) - Wall Street's main indexes were set to open lower on
03-19 21:15
BUZZ-Reviva Pharma plunges on highly dilutive stock-and-warrants offering
BUZZ-Reviva Pharma plunges on highly dilutive stock-and-warrants offering ** Reviva Pharmaceuticals RVPH.O shares plunging 45% to record low $1.03 premarket after follow-on offering priced ** RVPH late Weds sold ~6.7 mln shares along with two series of accompanying warrants at $1.50 for $10 mln gros
03-19 19:44
BRIEF-Reviva Pharmaceuticals Announces Pricing Of $10 Million Public Offering At $1.50 Per Share
BRIEF-Reviva Pharmaceuticals Announces Pricing Of $10 Million Public Offering At $1.50 Per Share March 18 (Reuters) - Reviva Pharmaceuticals Holdings Inc RVPH.O : REVIVA PHARMACEUTICALS HOLDINGS, INC. ANNOUNCES PRICING OF $10 MILLION PUBLIC OFFERING REVIVA PHARMACEUTICALS HOLDINGS INC - PRICES PUBLI
03-19 10:35
Reviva Pharmaceuticals Holdings shares are trading lower after the company announced a proposed public offering.
Reviva Pharmaceuticals Holdings shares are trading lower after the company anno...
03-19 04:17
Reviva Pharmaceuticals Commences Common Stock Offering; Terms Undisclosed
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system
03-19 04:11
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
Reviva Pharmaceuticals Holdings, Inc. plans to offer shares of its common stock and warrants in a public offering to fund research and development activities, including its RECOVER-2 Phase 3 trial for brilaroxazine in schizophrenia, as well as for working capital and general corporate purposes. A.G.P./Alliance Global Partners is acting as the sole placement agent. The offering is subject to market conditions and SEC approval. Proceeds will also s...
03-18 20:10
D. Boral Capital Downgrades Reviva Pharmaceuticals to Hold
D. Boral Capital analyst Jason Kolbert downgrades Reviva Pharmaceuticals (NASDAQ:RVPH) from Buy to Hold.
03-06 05:39
Reviva Pharmaceuticals Announces One-for-Twenty Reverse Stock Split
An announcement from Reviva Pharmaceuticals Holdings ( ($RVPH) ) is now availab...
03-05 21:53
